Branford, CT, United States of America

Roger Hanselmann

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 59(Granted Patents)


Company Filing History:


Years Active: 2005-2018

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Roger Hanselmann: A Pioneer in Pharmaceutical Innovation

Introduction

Roger Hanselmann is an accomplished inventor based in Branford, CT, with a remarkable portfolio of 14 patents. His contributions to the field of pharmaceutical research and development have paved the way for innovative treatments targeting various diseases and disorders. Hanselmann's work exemplifies the intersection of chemistry and medicine, showcasing the impact of well-conceived inventions in health care.

Latest Patents

Among his latest notable patents is the development of solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid. This patent focuses on solid forms that comprise this compound, along with methods for preparing these forms and their applications in the treatment of numerous diseases and disorders. Additionally, Hanselmann has patented a process for making quinolone compounds, a significant advancement in synthesizing anti-infective agents. This invention emphasizes the efficiency of production, yielding a minimal percentage of dimeric impurity, thereby enhancing the safety and effectiveness of these compounds.

Career Highlights

Roger Hanselmann has been associated with prominent companies in the pharmaceutical industry, including Rib-X Pharmaceuticals and Melinta Therapeutics. At these organizations, he has contributed to developing innovative therapeutic solutions that address critical health issues. His role has significantly influenced the creation and optimization of drug candidates in both companies, underscoring his expertise in pharmaceutical sciences.

Collaborations

Throughout his career, Hanselmann has collaborated with skilled professionals, including Rongliang Lou and Jiacheng Zhou. These partnerships have fostered a productive environment for innovation, allowing for the exchange of ideas and the development of cutting-edge pharmaceutical products.

Conclusion

Roger Hanselmann's inventive contributions and his impactful career in pharmaceutical innovation continue to drive advancements in healthcare. His dedication to synthesizing new compounds and improving treatments epitomizes the spirit of invention necessary for overcoming health challenges. With his impressive collection of patents, Hanselmann remains a vital figure in the realm of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…